Zidovudine (Retrovir)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zidovudine (Retrovir), covering 2011-03-14 to 2014-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir [Phase 2]